Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,773
Total Claims
$2.4M
Drug Cost
519
Beneficiaries
$4,682
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+265%
Cost per patient vs peers
$4,682 vs $1,283 avg
+148%
Brand preference vs peers
22.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
79
Opioid Claims
$1,286
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,103 claims · $2.1M
Generic: 7,380 claims · $278K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 178 | $201K |
| Tirzepatide | 143 | $159K |
| Empagliflozin | 120 | $122K |
| Sitagliptin Phosphate | 112 | $116K |
| Patiromer Calcium Sorbitex | 80 | $116K |
| Dulaglutide | 84 | $110K |
| Epoetin Alfa | 22 | $103K |
| Dapagliflozin Propanediol | 90 | $94K |
| Sucroferric Oxyhydroxide | 31 | $82K |
| Dupilumab | 19 | $76K |
| Apixaban | 74 | $55K |
| Insulin Aspart | 34 | $50K |
| Omeprazole/Sodium Bicarbonate | 11 | $43K |
| Finerenone | 38 | $40K |
| Linagliptin | 38 | $37K |
Prescribing Profile
Patient Profile
73
Avg Age
57%
Female
2.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About